AP2005003367A0 - Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis. - Google Patents

Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis.

Info

Publication number
AP2005003367A0
AP2005003367A0 AP2005003367A AP2005003367A AP2005003367A0 AP 2005003367 A0 AP2005003367 A0 AP 2005003367A0 AP 2005003367 A AP2005003367 A AP 2005003367A AP 2005003367 A AP2005003367 A AP 2005003367A AP 2005003367 A0 AP2005003367 A0 AP 2005003367A0
Authority
AP
ARIPO
Prior art keywords
erythropoiesis
stimulators
glycerides
analogues
medium
Prior art date
Application number
AP2005003367A
Other languages
English (en)
Inventor
Penney Christopher
Gagnon Lyne
Laurin Pierre
Original Assignee
Prometic Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prometic Biosciences Inc filed Critical Prometic Biosciences Inc
Publication of AP2005003367A0 publication Critical patent/AP2005003367A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AP2005003367A 2003-02-07 2004-02-06 Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis. AP2005003367A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44545403P 2003-02-07 2003-02-07
PCT/GB2004/000457 WO2004069237A1 (en) 2003-02-07 2004-02-06 Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis

Publications (1)

Publication Number Publication Date
AP2005003367A0 true AP2005003367A0 (en) 2005-09-30

Family

ID=32850990

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2005003367A AP2005003367A0 (en) 2003-02-07 2004-02-06 Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis.

Country Status (28)

Country Link
US (1) US9682054B2 (xx)
EP (1) EP1592416B1 (xx)
JP (1) JP5390070B2 (xx)
KR (1) KR101120775B1 (xx)
CN (1) CN100427081C (xx)
AP (1) AP2005003367A0 (xx)
AR (1) AR043120A1 (xx)
AT (1) ATE419846T1 (xx)
AU (1) AU2004210193B2 (xx)
BR (1) BRPI0407276A (xx)
CA (1) CA2515160C (xx)
CY (1) CY1108963T1 (xx)
DE (2) DE602004018902D1 (xx)
DK (1) DK1592416T3 (xx)
EA (1) EA009939B1 (xx)
ES (1) ES2255467T3 (xx)
IL (1) IL170057A (xx)
JO (1) JO2705B1 (xx)
MA (1) MA27664A1 (xx)
MX (1) MXPA05008382A (xx)
MY (1) MY140913A (xx)
NO (1) NO334085B1 (xx)
NZ (1) NZ541593A (xx)
PT (1) PT1592416E (xx)
SI (1) SI1592416T1 (xx)
TN (1) TNSN05189A1 (xx)
WO (1) WO2004069237A1 (xx)
ZA (1) ZA200506246B (xx)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA12506A (en) * 2001-04-18 2006-05-29 Prometic Biosciences Inc Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors.
US20070219131A1 (en) * 2004-04-15 2007-09-20 Ben-Sasson Shmuel A Compositions capable of facilitating penetration across a biological barrier
AU2005329255B2 (en) * 2004-04-15 2010-09-30 Chiasma, Inc. Compositions capable of facilitating penetration across a biological barrier
EP2314617B1 (en) 2004-07-23 2015-06-24 Acceleron Pharma Inc. ActRII receptor polypeptides
JP2008511553A (ja) * 2004-09-03 2008-04-17 プロメティック バイオサイエンシズ インコーポレーテッド 免疫調節活性および化学防護活性を有する置換型プリニル誘導体ならびにその単独使用または中鎖長の脂肪酸もしくはグリセリドとの併用
BRPI0516827A (pt) * 2004-10-01 2008-09-23 Prometic Biosciences Inc alcoóis graxos de comprimento de cadeia médio como estimuladores de hematopoese
US8071580B2 (en) * 2004-10-01 2011-12-06 Prometic Biosciences Inc. Medium-chain length fatty alcohols as stimulators of hematopoiesis
US8128933B2 (en) 2005-11-23 2012-03-06 Acceleron Pharma, Inc. Method of promoting bone growth by an anti-activin B antibody
CN104844713B (zh) 2005-11-23 2021-05-14 阿塞勒隆制药公司 Activin-ActRIIa拮抗剂及其促进骨骼生长的应用
US8895016B2 (en) 2006-12-18 2014-11-25 Acceleron Pharma, Inc. Antagonists of activin-actriia and uses for increasing red blood cell levels
BRPI0806861A2 (pt) 2007-02-01 2014-08-05 Acceleron Pharma Inc Antagonistas de ativina-actriia e usos para tratar ou prevenir câncer de mama
TW201940502A (zh) 2007-02-02 2019-10-16 美商艾瑟勒朗法瑪公司 衍生自ＡｃｔＲＩＩＢ的變體與其用途
TWI525102B (zh) 2007-02-09 2016-03-11 艾瑟勒朗法瑪公司 包含ＡｃｔＲＩＩａ-Ｆｃ融合蛋白的醫藥組合物；ＡｃｔＲＩＩａ-Ｆｃ融合蛋白於治療或預防與癌症相關的骨質流失之用途；ＡｃｔＲＩＩａ-Ｆｃ融合蛋白於治療或預防多發性骨髓瘤之用途
CN103877564A (zh) 2007-09-18 2014-06-25 阿塞勒隆制药公司 活化素-actriia拮抗剂和减少或抑制fsh分泌的用途
MY151439A (en) * 2007-11-02 2014-05-30 Prometic Biosciences Inc Medium-chain length fatty acids and glycerides as nephroprotection agents
TWI448290B (zh) * 2007-12-19 2014-08-11 Prometic Biosciences Inc 與健擇他濱（ｇｅｍｃｉｔａｂｉｎｅ）組合用於胰臟癌之治療的中等鏈長脂肪酸、鹽類及三酸甘油酯
TWI784538B (zh) 2008-08-14 2022-11-21 美商艾瑟勒朗法瑪公司 使用ｇｄｆ阱以增加紅血球水平
US8216997B2 (en) 2008-08-14 2012-07-10 Acceleron Pharma, Inc. Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
MX2011002836A (es) 2008-09-17 2011-04-28 Chiasma Inc Composiciones farmaceúticas y métodos de administración relacionados.
CN102482339B (zh) 2009-06-08 2015-06-17 阿塞勒隆制药公司 用于增加产热脂肪细胞的方法
KR20180026795A (ko) 2009-06-12 2018-03-13 악셀레론 파마 인코포레이티드 절두된 ＡｃｔＲＩＩＢ-ＦＣ 융합 단백질
EP3838919A1 (en) * 2009-08-13 2021-06-23 Acceleron Pharma Inc. Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels
ES2658292T3 (es) 2009-11-17 2018-03-09 Acceleron Pharma, Inc. Proteínas ActRIIB y variantes y usos de las mismas con respecto a la inducción de la utrofina para el tratamiento de la distrofia muscular
CN103298832A (zh) 2010-11-08 2013-09-11 阿塞勒隆制药公司 Actriia结合剂及其用途
TWI572352B (zh) * 2012-03-01 2017-03-01 波麥堤克藥學Ｓｍｔ有限公司 用於製備具中鏈長度之脂肪酸的三酸甘油酯之方法
EP3964224A1 (en) 2012-11-02 2022-03-09 Celgene Corporation Activin-actrii antagonists and uses for use in treating renal disease
CN102973922B (zh) * 2012-12-18 2016-02-03 华东理工大学 一种融合蛋白的应用
BR122023023170A2 (pt) 2014-06-13 2024-02-20 Acceleron Pharma Inc. Uso de um antagonista de actrii no tratamento ou prevenção de úlcera cutânea associada com beta-talassemia
MA41052A (fr) 2014-10-09 2017-08-15 Celgene Corp Traitement d'une maladie cardiovasculaire à l'aide de pièges de ligands d'actrii
ES2946160T3 (es) 2014-12-03 2023-07-13 Celgene Corp Antagonistas de activina-ActRII y usos para tratar síndrome mielodisplásico
MA41462A (fr) 2015-02-03 2021-05-12 Chiasma Inc Méthode de traitement de maladies
US20170021029A1 (en) * 2015-04-15 2017-01-26 Jeffrey Charles Raber Topical formulations and uses
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871768A (en) * 1984-07-12 1989-10-03 New England Deaconess Hospital Corporation Dietary supplement utilizing ω-3/medium chain trigylceride mixtures
US7307166B1 (en) * 1987-10-28 2007-12-11 Wellstat Therapeutics Corporation Oxpurine nucleosides and their congeners, and acyl, derivatives thereof, for improvement of hematopoiesis
US5011852A (en) * 1988-07-25 1991-04-30 Applied Analytical Industries, Inc. Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs
JP3014119B2 (ja) * 1990-05-28 2000-02-28 雪印乳業株式会社 直腸投与用赤血球造血剤
JP3249147B2 (ja) 1990-06-01 2002-01-21 キリン−アムジエン・インコーポレーテツド 生理活性蛋白含有経口製剤
ATE147976T1 (de) * 1991-01-15 1997-02-15 Hemosphere Inc Protein nanomatrizen und verfahren zur herstellung
JPH05163160A (ja) * 1991-12-13 1993-06-29 Snow Brand Milk Prod Co Ltd 免疫低下に伴う感染症の予防及び治療用栄養剤
US5214035A (en) * 1992-04-16 1993-05-25 Hoechst-Roussel Agri-Vet Company Thixotropic formulations
US5318781A (en) * 1993-04-06 1994-06-07 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics
US20010003739A1 (en) * 1993-06-24 2001-06-14 Astrazeneca Ab Systemic administration of a therapeutic preparation
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
AU7082694A (en) 1994-05-10 1995-11-29 Kitasato Institute, The Hematopoietic stem cell proliferation accelerator
US5470861A (en) * 1994-08-04 1995-11-28 Hoffmann-La Roche Inc. Method of promoting hair growth
US5549905A (en) * 1994-10-18 1996-08-27 Clintec Nutrition Co. Enternal composition for pediatric patients
JPH08208510A (ja) 1994-11-03 1996-08-13 F Hoffmann La Roche Ag インターフェロン組成物
GB9516268D0 (en) 1995-08-08 1995-10-11 Danbiosyst Uk Compositiion for enhanced uptake of polar drugs from the colon
AUPN933396A0 (en) * 1996-04-17 1996-05-09 Pfizer Pty Limited Non-aqueuos oral-drench compositions containing avermectin compounds
US5851534A (en) 1996-05-03 1998-12-22 Dynagen, Inc. Methods for prevention and/or treatment of neutropenia
JPH10265380A (ja) 1997-03-17 1998-10-06 Bristol Myers Squibb Co 抗ガン剤
EP1009383A1 (en) * 1997-09-04 2000-06-21 Biozone Laboratories, Inc. Oral liposomal delivery system
WO1999025319A1 (en) * 1997-11-14 1999-05-27 Depotech Corporation Production of multivesicular liposomes
EP1032358B1 (en) * 1997-11-19 2005-05-18 Hercules Incorporated Fluidized polymer suspensions of cationic polysaccharides in emollients and use thereof in preparing personal care compositions
EP1061932B1 (en) * 1997-11-20 2006-01-25 Gil Ja Jhon Pharmaceutical composition containing extracts of cervus nippon antlers having growth-stimulating activities of hematopoietic stem cells and megakaryocytes
ATE271376T1 (de) * 1998-02-23 2004-08-15 Cilag Ag Int Liposomale erythropoietin-dispersion
ATE246506T1 (de) 1998-03-11 2003-08-15 Grelan Pharmaceutical Co Darmlösliche sprudelnde zusammensetzungen
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
JP2003513019A (ja) * 1999-09-27 2003-04-08 ソーナス ファーマシューティカルス，インコーポレイテッド トコール可溶性治療剤の組成物
US6835750B1 (en) * 2000-05-01 2004-12-28 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
DE60123603T2 (de) 2000-06-14 2007-08-16 William Leslie Diss Porter Lipide zur änderung des abwehrsystems
US6967028B2 (en) 2000-07-31 2005-11-22 Mainelab Prolonged release microspheres for injectable administration
IL142535A0 (en) 2001-04-11 2002-03-10 Yeda Res & Dev Pharmaceutical compositions for the treatment of inflammation
OA12506A (en) * 2001-04-18 2006-05-29 Prometic Biosciences Inc Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors.
US20040052836A1 (en) * 2002-09-13 2004-03-18 Li Luk Chiu Pharmaceutical compositions containing at least one stable liposphere having an improved shelf life
US6725510B1 (en) * 2003-04-25 2004-04-27 Almetta Clyburn Inclining coffin
KR101120813B1 (ko) 2003-07-25 2012-03-23 프로메틱 바이오사이언시즈 인코포레이티드 중-쇄 지방산 금속염의 제조 방법
JP2008511553A (ja) * 2004-09-03 2008-04-17 プロメティック バイオサイエンシズ インコーポレーテッド 免疫調節活性および化学防護活性を有する置換型プリニル誘導体ならびにその単独使用または中鎖長の脂肪酸もしくはグリセリドとの併用
US8071580B2 (en) 2004-10-01 2011-12-06 Prometic Biosciences Inc. Medium-chain length fatty alcohols as stimulators of hematopoiesis

Also Published As

Publication number Publication date
MA27664A1 (fr) 2005-12-01
PT1592416E (pt) 2009-04-03
CA2515160A1 (en) 2004-08-19
CN1753665A (zh) 2006-03-29
DK1592416T3 (da) 2009-04-20
NO20053994D0 (no) 2005-08-26
SI1592416T1 (sl) 2009-06-30
MXPA05008382A (es) 2005-11-04
CY1108963T1 (el) 2014-07-02
AR043120A1 (es) 2005-07-20
BRPI0407276A (pt) 2006-01-31
IL170057A (en) 2011-09-27
KR20050118671A (ko) 2005-12-19
NZ541593A (en) 2009-05-31
US20060128800A1 (en) 2006-06-15
ES2255467T1 (es) 2006-07-01
EP1592416B1 (en) 2009-01-07
MY140913A (en) 2010-01-29
NO20053994L (no) 2005-10-06
DE602004018902D1 (de) 2009-02-26
DE04708802T1 (de) 2006-06-22
JO2705B1 (ar) 2014-03-15
ATE419846T1 (de) 2009-01-15
CA2515160C (en) 2013-01-08
CN100427081C (zh) 2008-10-22
US9682054B2 (en) 2017-06-20
TNSN05189A1 (en) 2007-06-11
WO2004069237A1 (en) 2004-08-19
JP5390070B2 (ja) 2014-01-15
EA200501267A1 (ru) 2006-02-24
EP1592416A1 (en) 2005-11-09
EA009939B1 (ru) 2008-04-28
ZA200506246B (en) 2006-12-27
NO334085B1 (no) 2013-12-09
ES2255467T3 (es) 2009-05-01
AU2004210193B2 (en) 2007-07-12
AU2004210193A1 (en) 2004-08-19
KR101120775B1 (ko) 2012-04-18
JP2006516987A (ja) 2006-07-13

Similar Documents

Publication Publication Date Title
AP2005003367A0 (en) Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis.
IL195200A0 (en) Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
HK1085615A1 (en) Fatty acid desaturases from fungi
HK1102348A1 (en) Composition containing polyglycerol/medium-chain fatty acid ester
TW200504198A (en) Glyceride compositions and methods of making and using same
EP1685218A4 (en) Fatty acid esters and their use
PL1753852T3 (pl) Kompozycje o własnościach wspomagających zdrowie i odżywianie zawierające interestryfikowane lipidy i estry fitosteroli, i odpowiednie sposoby
EP1479649A4 (en) CORRUGATED CAVITY CORE-STRUCTURE STRUCTURE COMPRISING THE CORE-ENVELOPE STRUCTURE AS A COMPONENT, AND PROCESS FOR PREPARING THE SAME
IL158131A0 (en) Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism
AU2003202259A8 (en) Lipid compositions, production thereof and of esters
EP1500645A4 (en) ASTAXANTHINE FATTY ACID ESTERS WITH MEDIUM CHAIN LENGTH, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THE ESTER
IL183246A0 (en) Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same
HK1081728A1 (en) High-speed axial connector
PL377614A1 (pl) Kompozycje zawierające kwasy tłuszczowe i aminokwasy
EP1568677A4 (en) POLYGLYCEROLS, ESTER OF FATTY ACID / POLYGLYCEROL, AND PROCESSES FOR PRODUCING THE SAME
AP2006003523A0 (en) Preparation of metal salts of medium-chain fatty acids.
AU2003259112A8 (en) Enzymatic process for the preparation of foods, feedstuffs and ingredients therefor
TWI339586B (en) Solid preparation comprising pioglitazone or salt thereof,glimpiride and polyoxyethylene sorbitan fatty acid ester
PL1799027T3 (pl) Rośliny o nasionach niezawierających nasyconych kwasów tłuszczowych lub o zmniejszonej zawartości kwasów tłuszczowych i olej pozyskany z takich nasion
HK1082026A1 (en) Animal and vegetable oils combustors
IL172416A0 (en) Modified human acid sphingomyelinase having increased activity, and methods for making the same
PL376148A1 (en) Vitamin d analogues, compositions comprising said analogues and their use
HK1111358A1 (en) Medium-chain length fatty alcohols as stimulators of hematopoiesis
EP1623018A4 (en) MPTENE AS PTEN / IGF PATH MODIFICATORS AND USE METHOD
GB0120415D0 (en) Palatable high fat composition